SIGA Technologies, Inc.

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $41.0M $6.2M $3.8M $2.6M $81.1M $7.0M $81.5M $10.0M
Cost of Revenue $17.6M $2.9M $3.0M $1.0M $25.6M $157.7K $14.1M $1.6M
Gross Profit $23.4M $3.3M $804.5K $1.6M $55.6M $6.9M $67.3M $8.4M
Gross Margin 57.2% 52.9% 21.2% 61.8% 68.5% 97.8% 82.7% 83.8%
Operating Expenses
Research & Development $4.4M $3.9M $5.0M $7.1M $4.4M $3.5M $3.3M $3.0M
SG&A Expense $5.1M $4.7M $5.3M $4.8M $5.5M $5.7M $6.9M $4.8M
Operating Income $13.9M $-5.3M $-9.5M $-10.2M $45.7M $-2.3M $57.1M $542.1K
Operating Margin 33.9% -85.2% -250.4% -390.2% 56.3% -32.0% 70.1% 5.4%
Interest Expense — — — — — — — —
Pretax Income $14.9M $-4.0M $-8.0M $-8.4M $47.3M $-570.4K $58.6M $1.9M
Income Tax Expense $2.4M $-589.4K $-2.5M $-2.0M $11.8M $-162.2K $12.8M $528.6K
Net Income $12.5M $-3.5M $-5.4M $-6.4M $35.5M $-408.2K $45.8M $1.3M
Net Margin 30.4% -55.3% -143.1% -243.0% 43.7% -5.8% 56.2% 13.4%
EPS (Basic) $0.17 $-0.05 $-0.07 $-0.09 $0.50 $-0.01 $0.64 $0.02
EPS (Diluted) $0.17 $-0.05 $-0.07 $-0.09 $0.49 $-0.01 $0.63 $0.02
Shares Outstanding (Basic) 71.8M 71.6M 71.5M 71.6M 71.5M 71.4M 71.3M 71.4M
Shares Outstanding (Diluted) 71.9M 71.6M 71.9M 71.6M 71.7M 71.4M 71.9M 71.8M
Dividends Per Share $0.60 $0.60 — — $0.60 — — $0.60
← Newer Page 1 of 5 Older →